The invention provides methods and compositions for treatment of bacterial
infections. Methods of the invention include administration of
dalbavancin for treatment of a bacterial infection, in particular a
Gram-positive bacterial infection of skin and soft tissue. Dosing regimes
include once weekly administration of dalbavancin, which often remains at
therapeutic levels in the bloodstream for at least one week, providing
prolonged therapeutic action against a bacterial infection.